Mirror Mirror on the Wall, Who Is the Fairest of Them All

Slides:



Advertisements
Similar presentations
Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Advertisements

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.
Development of Renal Cysts after Crizotinib Treatment in Advanced ALK-Positive Non– Small-Cell Lung Cancer Yen-Ting Lin, MD, Yu-Fen Wang, MD, James Chih-Hsin.
A Hole in the Heart Journal of Thoracic Oncology
Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung  Sai-Hong.
Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non– Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor.
Phase II Study of Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), and Celecoxib, a Cyclooxygenase-2 (COX-2) Inhibitor,
Two Classic Lyrics Joined by a Contemporary Tune—Environmental Pro-Carcinogen Exposure and Genetic Susceptibility in Lung Cancer Risk  Ping Yang, MD,
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
SC17.02 Lung Cancer in China: Challenges and Perspectives
James B. Yu, MD, Lynn D. Wilson, MD, MPH, Frank C. Detterbeck, MD 
ALK FISH and IHC: You Cannot Have One without the Other
Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D
Ellen M. Schultz, MS, Gerard A. Silvestri, MD, MS, Michael K
NA  Journal of Thoracic Oncology 
Electronic Updates for JTO Readers
Hedgehog Signaling Pathway and Lung Cancer
IA05.01 Lung Cancer Cases Journal of Thoracic Oncology
The Moth-Eaten Lung Journal of Thoracic Oncology
Frank Detterbeck, MD  Journal of Thoracic Oncology 
Ziad Thotathil, MD, FRCR, Jeremy Long, FRACP 
Pulmonary Metastasectomy: A Survey of Current Practice Amongst Members of the European Society of Thoracic Surgeons  Eveline Internullo, MD, Stephen D.
Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.
Successful Treatment with Erlotinib after Gefitinib-Induced Severe Interstitial Lung Disease  Masayuki Takeda, MD, PhD, Isamu Okamoto, MD, PhD, Chihiro.
The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials  Krista.
Meta-Analysis of First-Line Therapies in Advanced Non–Small-Cell Lung Cancer Harboring EGFR-Activating Mutations  Benjamin Haaland, PhD, Pui San Tan,
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors  Benny Weksler, MD, Anthony Holden, MD, Jennifer.
Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database  Laura C. Caprario, MD, MS,
Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review  Arianna Casagrande, MD, Federica Pederiva,
Socioeconomic Status Is Associated with Depressive Severity Among Patients with Advanced Non–Small-Cell Lung Cancer: Treatment Setting and Minority Status.
A Hole in the Heart Journal of Thoracic Oncology
In This Issue Journal of Thoracic Oncology
A Different Method in Diagnosis of Multiple Primary Lung Cancer
Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS 
Vamsidhar Velcheti, MD  Journal of Thoracic Oncology 
In This Issue Journal of Thoracic Oncology
Heidi B. Rolke, Frode Gallefoss  Journal of Thoracic Oncology 
Mitotic Inhibitors Journal of Thoracic Oncology
A Translational View of the Molecular Pathogenesis of Lung Cancer
Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non– Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor.
Aglaya G. Iyevleva, MD, PhD  Journal of Thoracic Oncology 
MTP13-01: Indications and limitations of bronchoscopy
Role of Postoperative Radiotherapy in Nonlocalized Thymoma
Conditional Survival of Malignant Thymoma Using National Population-Based Surveillance, Epidemiology, and End Results (SEER) Registry (1973–2011)  Ellen.
Compound Uncommon EGFR Mutations in a Patient with Advanced NSCLC and Durable Response to Sequential EGFR Targeted Therapies  Mary Linton B Peters, MD,
Pulmonary Metastasectomy in Breast Cancer
Phase I Study of Lenalidomide in Solid Tumors
T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)
Jie Huang, Juan Peng, Linlang Guo, MD, PhD 
Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?
In This Issue Journal of Thoracic Oncology
Table of Contents Journal of Thoracic Oncology
Genetic Changes in Squamous Cell Lung Cancer: A Review
European Lung Cancer Conference (ELCC) 2016 Organisation
Bryan M. Burt, MD  The Journal of Thoracic and Cardiovascular Surgery 
Discussion The Journal of Thoracic and Cardiovascular Surgery
Novel Drugs—Miscellaneous Category
IASLC 6th Latin American Conference on Lung Cancer
Christina S. Baik, MD, MPH, Marc C. Chamberlain, MD, Laura Q. Chow, MD 
APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28
David Garfield, MD  Journal of Thoracic Oncology 
Epidemiology of Thymoma and Associated Malignancies
Two Rare Exon 21 EGFR Mutations in Patients Treated with Gefitinib
Cytokine Gene Therapy for Malignant Pleural Mesothelioma
A Review of First-Line Treatment for Small-cell Lung Cancer
Mark A. Socinski, MD  Journal of Thoracic Oncology 
Robert Comis, MD, The Passing of a “Lung Man”
Ana Luque, MD, Edurne Arriola, MD, PhD  Journal of Thoracic Oncology 
Presentation transcript:

Mirror Mirror on the Wall, Who Is the Fairest of Them All Tony S.K. Mok, MD  Journal of Thoracic Oncology  Volume 9, Issue 4, Pages 431-432 (April 2014) DOI: 10.1097/JTO.0000000000000123 Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 Molecular structure of gefitinib and erlotinib. Journal of Thoracic Oncology 2014 9, 431-432DOI: (10.1097/JTO.0000000000000123) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions